EGFR in enamel matrix derivative-induced gingival fibroblast mitogenesis

E. Zeldich, R. Koren, M. Dard, C. Nemcovsky, M. Weinreb*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We previously reported that EMD (Enamel Matrix Derivative) induces proliferation of human gingival fibroblasts via activation of Extracellular Regulated Kinase (ERK), and this study assessed the possible mediatory role of EGFR (Epidermal Growth Factor Receptor) in this effect. Treatment of gingival fibroblasts with EMD resulted in tyrosine phosphorylation of the EGFR, as assessed by immunoblotting and ELISA, while EMD-induced ERK activation and thymidine incorporation were markedly inhibited (∼ 40-50%) by a specific EGFR tyrosine kinase inhibitor. Using appropriate inhibitors, we established that EMD-induced EGFR activation is largely due to shedding of HB-EGF (Heparin-binding EGF) from the cell membrane via a metalloproteinase-mediated process. Finally, the addition of PP1, a Src family inhibitor, abrogated both EGFR phosphorylation and ERK activation. Taken together, these results indicate that, at least in human gingival fibroblasts, EMD-induced ERK activation and proliferation are partially due to a Src-dependent, metalloproteinase-mediated transaetivation of EGFR.

Original languageEnglish
Pages (from-to)850-855
Number of pages6
JournalJournal of Dental Research
Issue number9
StatePublished - Sep 2008


  • EGFR
  • ERK
  • Emdogain
  • Enamel matrix derivative
  • Gingival fibroblasts


Dive into the research topics of 'EGFR in enamel matrix derivative-induced gingival fibroblast mitogenesis'. Together they form a unique fingerprint.

Cite this